← Evidence map

ArticleHepatology (Baltimore, Md.)2018

HCV and nonhepatic malignancy: Is pre-emptive direct-acting antiviral therapy indicated prior to treatment?

Michael Kriss et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2018

this papercites it

HCV and nonhepatic malignancy: Is pre-emptive direct-acting antiviral therapy indicated prior to treatment? | OpenQuestion